AstraZeneca ($AZN) paid big bucks for MedImmune 5 years ago, and it's ploughed money into the biotech group ever since. Has that investment paid off? Not yet. The real question is, will it ever? Report
AstraZeneca ($AZN) paid big bucks for MedImmune 5 years ago, and it's ploughed money into the biotech group ever since. Has that investment paid off? Not yet. The real question is, will it ever? Report